Ledger.Open graph →

SEC Form D · filed May 6, 2022

Facible BioDiagnostics, Inc

Offering

$1.8M

Sold

$862K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

MERIDIAN, ID

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Micah Kormylo · MERIDIAN, IDExec Matthew Hawkins · MERIDIAN, IDDirector Clementine Gibard Bohachek · MERIDIAN, IDExec Eric Hayden · MERIDIAN, IDDirector Casi Wyatt · MERIDIAN, IDDirector Steven Burden · MERIDIAN, IDExec · Director Brent Fawson · MERIDIAN, IDExec Dan Geraci · Tucson, AZDirector Shawn Bradley · Ottawa, Ontario, CanadaExec Travis M. Heriaud · Scottsdale, AZDirector Mark Tayles · Ottawa, Ontario, CanadaDirector Kenneth Bradley · Ottawa, Ontario, CanadaExec Danna M. Murphy · Scottsdale, AZExec · Director Alexander A. Wong · Denver, COExec Shaker J. Sadasivam · CAMBRIDGE, MADirector Mark G. Currie · CAMBRIDGE, MAExec Patrik Burnas · Stockholm, V7Director Josh G. Israel · Boston, MAExec · Director Hanna C. Shuvalova · Chicago, ILExec Douglas Margerum · Bethesda, MDExec Stephen Margerum · Bethesda, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗